Polar Capital Holdings Plc

Q3 2022 13F-HR Detailed Holdings

Location
London, X0
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
416
Total value ($000)
$15,693,872
Net value change ($000)
-1,333,010 (-7.8%)
New positions
21
Sold out positions
45
Turnover %
6.7%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/15/2022 Next filing: 2/14/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Revance Therapeutics, Inc. 77,389 179.6%
DXCM 67,247 NEW
PEN 65,813 3145.9%
BDX 55,170 NEW
ABNB 54,616 106.6%
GTLB 51,530 NEW
TER 48,362 NEW
NET 44,297 329.1%
AMZN 43,441 32.7%
GLOB 42,564 301.1%
Top Reduces (Value $000, Stocks/ETFs)
Ferguson (Jersey) Ltd -780,534 -19.0%
MSFT -101,204 -11.6%
ADBE -85,203 -100.0%
STE -78,203 -100.0%
BABA -69,746 -50.0%
FIVN -65,089 -58.6%
CVS -62,913 -100.0%
NBIX -57,977 -75.8%
ZM -57,296 -100.0%
NVST -56,365 -88.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Polar Capital LLP 028-13167